Reaction of 2-hetarylacetonitriles with ethyl 2-alkylsulfanyl-4-chloro-5-pyrimidinecarboxylates. Synthesis of new condensed pyrimidines
-
Add time:07/16/2019 Source:sciencedirect.com
Reactions of 2-hetarylacetonitriles 1 with ethyl 2-alkylsulfanyl-4-chloro-5-pyrimidinecarboxylates 4 were studied. The interaction of pyridine, benzimidazole and benzothiazole derivatives 1a–d affords a series of new condensed pyridopyrimidines 5–7. In the case of benzoxazole- and 4-arylthiazole derivatives 1e–h ethyl 4-[(2-hetaryl)-cyano-methyl]-2-alkylsulfanylpyrimidine-5-carboxylates 9a–f were formed. Reactions of quinazoline derivatives 1i,k afford stable intermediates 9h,i which formed the cyclic compound 12 of angular structure in the presence of potash. The influence of the basicity of heterocycles and of steric factors on the intramolecular acylation reaction was studied.
We also recommend Trading Suppliers and Manufacturers of 1-(2-BUTYL)-4-(2-CHLORO-ETHYL)-PIPERAZINE X 2 HCL (cas 722491-43-2). Pls Click Website Link as below: cas 722491-43-2 suppliers
Prev:Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors
Next:Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- 5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors07/19/2019
- Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as angiotensin converting enzyme (ACE) inhibitors07/18/2019
- Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors07/17/2019
- Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors07/15/2019
- Synthesis of homofascaplysin B, C and analogues by the photocyclization of 3-acyl-2-chloro-1-[2-(indol-3-yl)ethyl]indoles07/14/2019


